Physician profile
Hemal K Patel
NPI 1548471600
$963.32
in general payments reported to CMS, 2019-2025
8 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2023: $228 · 2024: $380 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $287.79 | 2023-2025 | |
| Medical Device Business Services, INC. | $148.43 | 2019 | |
| Lilly USA, LLC | $120.34 | 2025 | Omvoh |
| Ocular Therapeutix, INC. | $113.74 | 2024 | Dextenza |
| Ethicon US, LLC | $102.64 | 2024 | Linx Reflux Management System |
| E.R. Squibb & Sons, L.L.C. | $87.11 | 2023 | Zeposia |
| Novo Nordisk INC | $84.71 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Ucb, INC. | $18.56 | 2023 | Briviact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.